Combination of macrophage inflammatory protein 1 alpha with existing therapies to enhance the antitumor effects on murine hepatoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeong, Keun-Yeong | - |
dc.contributor.author | Lee, Eun-Jung | - |
dc.contributor.author | Yang, Seung-Hyun | - |
dc.contributor.author | Seong, Jinsil | - |
dc.date.available | 2020-02-28T10:44:21Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2015-01 | - |
dc.identifier.issn | 0449-3060 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/10884 | - |
dc.description.abstract | Existing therapies such as irradiation or sorafenib have limited success in the treatment of hepatocellular carcinoma (HCC) due to tumor recurrence and metastasis. Therefore, combination with other therapeutics is often considered. Macrophage inflammatory protein-1 alpha (MIP-1 alpha) is a member of a family of chemoattractant cytokines that can induce the migration of monocytes, which in turn can play a role in fighting tumors. This study investigated whether intravenous injection of MIP-1a in conjunction with irradiation or sorafenib could enhance the antitumor effects on murine hepatoma. An HCa-I tumor was grown on the right thigh of each C3H/HeN mouse. Mice were then treated with 10 Gy of irradiation, sorafenib, or a combination of MIP-1 alpha with either irradiation or sorafenib, and antitumor and antimetastatic effects were then investigated. To understand the mechanisms, changes in the level of immunological markers were also evaluated. Combination treatment of MIP-1 alpha with irradiation or sorafenib resulted in a significant enhancement of antitumor effects, prevention of lung metastasis and increase in host survival. This was achieved by significantly increasing the levels of the immunological markers: Cluster Differentiation (CD) 8, CD107A and CD11C. We conclude that a combination treatment of MIP-1 alpha with irradiation or sorafenib would be a useful strategy for management of hepatoma. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | OXFORD UNIV PRESS | - |
dc.relation.isPartOf | JOURNAL OF RADIATION RESEARCH | - |
dc.subject | ADVANCED HEPATOCELLULAR-CARCINOMA | - |
dc.subject | CANCER STEM-CELLS | - |
dc.subject | OF-THE-LITERATURE | - |
dc.subject | RADIATION-THERAPY | - |
dc.subject | DENDRITIC CELLS | - |
dc.subject | SORAFENIB | - |
dc.subject | MICE | - |
dc.subject | LYMPHOCYTES | - |
dc.subject | MIP-1-ALPHA | - |
dc.subject | METASTASIS | - |
dc.title | Combination of macrophage inflammatory protein 1 alpha with existing therapies to enhance the antitumor effects on murine hepatoma | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000350245600005 | - |
dc.identifier.doi | 10.1093/jrr/rru077 | - |
dc.identifier.bibliographicCitation | JOURNAL OF RADIATION RESEARCH, v.56, no.1, pp.37 - 45 | - |
dc.identifier.scopusid | 2-s2.0-84922443680 | - |
dc.citation.endPage | 45 | - |
dc.citation.startPage | 37 | - |
dc.citation.title | JOURNAL OF RADIATION RESEARCH | - |
dc.citation.volume | 56 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Jeong, Keun-Yeong | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | hepatocellular carcinoma | - |
dc.subject.keywordAuthor | metastasis | - |
dc.subject.keywordAuthor | irradiation | - |
dc.subject.keywordAuthor | sorafenib | - |
dc.subject.keywordAuthor | MIP-1 alpha | - |
dc.subject.keywordPlus | ADVANCED HEPATOCELLULAR-CARCINOMA | - |
dc.subject.keywordPlus | CANCER STEM-CELLS | - |
dc.subject.keywordPlus | OF-THE-LITERATURE | - |
dc.subject.keywordPlus | RADIATION-THERAPY | - |
dc.subject.keywordPlus | DENDRITIC CELLS | - |
dc.subject.keywordPlus | SORAFENIB | - |
dc.subject.keywordPlus | MICE | - |
dc.subject.keywordPlus | LYMPHOCYTES | - |
dc.subject.keywordPlus | MIP-1-ALPHA | - |
dc.subject.keywordPlus | METASTASIS | - |
dc.relation.journalResearchArea | Life Sciences & Biomedicine - Other Topics | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Biology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.